Location: New York, NY
CIK: 0001773195 · Show all filings
Period: Q1 2021 (← Previous) (Next →)
Filing Date: May 14, 2021
Total Value: $294M (98.6% shares, 1.4% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF TR | 110,000 | $43.6M | 14.8% | — | — | Put | 78462F103 |
| BBIO | BRIDGEBIO PHARMA INC | 577,500 | $35.57M | 12.1% | $60.81 | +7.6% | COM | 10806X102 |
| ARKG | ARK ETF TR | 240,000 | $21.3M | 7.2% | — | — | Put | 00214Q302 |
| — | MORPHIC HLDG INC | 195,000 | $12.34M | 4.2% | $52.99 | — | COM | 61775R105 |
| — | CURIS INC | 1,000,000 | $11.32M | 3.8% | $8.19 | — | COM NEW | 231269200 |
| VRTX | VERTEX PHARMACEUTICALS INC | 50,000 | $10.74M | 3.6% | $229.44 | -4.3% | Call | 92532F100 |
| — | VINCERX PHARMA INC | 543,010 | $10.48M | 3.6% | $20.50 | — | COM NEW | 92731L106 |
| KURA | KURA ONCOLOGY INC | 365,000 | $10.32M | 3.5% | $34.13 | -7.3% | COM | 50127T109 |
| — | ARYA SCIENCES ACQUISITION CO | 689,000 | $9.494M | 3.2% | $12.50 | — | COM CL A | G3166W106 |
| — | ARYA SCIENCES ACQU CORP IV | 700,000 | $7.331M | 2.5% | $10.47 | — | CL A | G31659108 |
| — | ACCELERON PHARMA INC | 45,000 | $6.102M | 2.1% | $127.93 | — | COM | 00434H108 |
| ACRS | ACLARIS THERAPEUTICS INC | 222,267 | $5.601M | 1.9% | $19.56 | 0.0% | COM | 00461U105 |
| TVTX | TRAVERE THERAPEUTICS INC | 220,000 | $5.493M | 1.9% | $27.63 | 0.0% | COM | 89422G107 |
| — | INARI MED INC | 50,000 | $5.35M | 1.8% | $103.06 | — | COM | 45332Y109 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 190,500 | $4.26M | 1.4% | — | — | Call | 87164F105 |
| — | RETROPHIN INC | 4,000,000 | $4.069M | 1.4% | $1.01 | — | NOTE 2.500% 9/1 | 761299AB2 |
| — | LIFESCI ACQUISITION II CORP | 400,000 | $4.056M | 1.4% | $10.54 | — | COM | 53229E103 |
| RCKT | ROCKET PHARMACEUTICALS INC | 85,000 | $3.771M | 1.3% | $36.45 | +50.6% | COM | 77313F106 |
| OCUL | OCULAR THERAPEUTIX INC | 227,500 | $3.733M | 1.3% | $15.00 | +28.4% | COM | 67576A100 |
| — | CEREVEL THERAPEUTICS HLDNG I | 270,000 | $3.707M | 1.3% | $16.58 | — | COM | 15678U128 |
| ALDX | ALDEYRA THERAPEUTICS INC | 300,000 | $3.564M | 1.2% | $10.02 | +15.0% | COM | 01438T106 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 77,500 | $3.363M | 1.1% | $43.05 | 0.0% | COM | 98943L107 |
| — | HORIZON THERAPEUTICS PUB L | 35,000 | $3.221M | 1.1% | $73.16 | — | SHS | G46188101 |
| MREO | MEREO BIOPHARMA GROUP PLC | 900,000 | $3.033M | 1.0% | $3.52 | — | ADS | 589492107 |
| — | MEDICUS SCIENCES ACQUISITION | 300,000 | $2.955M | 1.0% | $9.85 | — | UNIT 99/99/9999 | G5960S116 |
| — | CURIS INC | 250,000 | $2.83M | 1.0% | $8.19 | — | Call | 231269200 |
| — | CHINOOK THERAPEUTICS INC | 175,000 | $2.72M | 0.9% | $15.81 | — | COM | 16961L106 |
| — | CYCLACEL PHARMACEUTICALS INC | 380,000 | $2.702M | 0.9% | $7.33 | — | COM | 23254L603 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 130,000 | $2.678M | 0.9% | $20.10 | +14.3% | COM NEW | 15117B202 |
| — | ESSA PHARMA INC | 90,000 | $2.615M | 0.9% | $29.06 | — | COM NEW | 29668H708 |
| ASND | ASCENDIS PHARMA A/S | 20,000 | $2.578M | 0.9% | $147.85 | — | SPONSORED ADR | 04351P101 |
| ASND | ASCENDIS PHARMA A/S | 20,000 | $2.578M | 0.9% | $147.85 | — | Put | 04351P101 |
| KALV | KALVISTA PHARMACEUTICALS INC | 100,000 | $2.569M | 0.9% | $22.17 | +18.5% | COM | 483497103 |
| — | ZYMEWORKS INC | 80,000 | $2.526M | 0.9% | $44.32 | — | COM | 98985W102 |
| — | HEALTH SCIENCES ACQ CORP 2 | 225,000 | $2.518M | 0.9% | $12.63 | — | ORD SHS | G4411D109 |
| LUNG | PULMONX CORP | 45,000 | $2.058M | 0.7% | $53.63 | +6.9% | COM | 745848101 |
| — | SPRINGWORKS THERAPEUTICS INC | 27,000 | $1.986M | 0.7% | $73.56 | — | COM | 85205L107 |
| — | RUBIUS THERAPEUTICS INC | 70,000 | $1.855M | 0.6% | — | — | Call | 78116T103 |
| — | SUTRO BIOPHARMA INC | 80,000 | $1.821M | 0.6% | $21.71 | — | COM | 869367102 |
| — | HIGHCAPE CAP ACQUISITION COR | 150,000 | $1.788M | 0.6% | $11.92 | — | COM SL A | 42984L105 |
| BFLY | BUTTERFLY NETWORK INC | 100,000 | $1.683M | 0.6% | $19.79 | 0.0% | COM CL A | 124155102 |
| — | BLUEBIRD BIO INC | 50,000 | $1.508M | 0.5% | — | — | Call | 09609G100 |
| — | MERSANA THERAPEUTICS INC | 85,000 | $1.375M | 0.5% | $22.32 | — | COM | 59045L106 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 50,000 | $1.295M | 0.4% | $25.31 | 0.0% | COM | 74366E102 |
| — | BELLUS HEALTH INC NEW | 300,000 | $1.152M | 0.4% | $3.84 | — | COM NEW | 07987C204 |
| IMVT | IMMUNOVANT INC | 70,000 | $1.123M | 0.4% | $46.23 | -43.0% | Call | 45258J102 |
| — | BCTG ACQUISITION CORP | 100,000 | $1.112M | 0.4% | $11.44 | — | COM | 05492W103 |
| GLPG | GALAPAGOS NV | 12,500 | $964K | 0.3% | $77.12 | — | SPON ADR | 36315X101 |
| CYTK | CYTOKINETICS INC | 40,000 | $930K | 0.3% | $18.28 | +16.8% | COM NEW | 23282W605 |
| — | VINCERX PHARMA INC | 218,000 | $881K | 0.3% | $3.40 | — | *W EXP 12/24/2025 | 92731L114 |
| — | GLOBAL BLOOD THERAPEUTICS IN | 20,000 | $815K | 0.3% | $43.32 | — | COM | 37890U108 |
| AFIB | ACUTUS MED INC | 60,000 | $802K | 0.3% | $22.51 | 0.0% | COM | 005111109 |
| MGNX | MACROGENICS INC | 25,000 | $796K | 0.3% | $24.28 | 0.0% | COM | 556099109 |
| — | CHARDAN HEALTHCR ACQSTN 2 CO | 75,000 | $789K | 0.3% | $10.52 | — | UNIT 99/99/9999 | 15957T206 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 24,600 | $779K | 0.3% | $40.06 | +3.5% | COM | 462260100 |
| CCCC | C4 THERAPEUTICS INC | 20,000 | $740K | 0.3% | $29.00 | +37.2% | COM STK | 12529R107 |
| — | ASLAN PHARMACEUTICALS LTD | 200,000 | $670K | 0.2% | $3.35 | — | ADS | 04522R101 |
| MRNA | MODERNA INC | 5,000 | $655K | 0.2% | — | — | Call | 60770K107 |
| — | X4 PHARMACEUTICALS INC | 75,000 | $646K | 0.2% | $8.61 | — | COM | 98420X103 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 10,000 | $625K | 0.2% | $57.68 | 0.0% | COM | G31249108 |
| PCVX | VAXCYTE INC | 30,000 | $593K | 0.2% | $37.18 | -32.3% | COM | 92243G108 |
| — | IMMATICS N.V | 200,000 | $590K | 0.2% | $2.88 | — | *W EXP 07/01/2020 | N44445117 |
| AXSM | AXSOME THERAPEUTICS INC | 10,000 | $566K | 0.2% | $74.78 | -5.9% | COM | 05464T104 |
| BYSI | BEYONDSPRING INC | 50,000 | $554K | 0.2% | $13.15 | -1.8% | SHS | G10830100 |
| — | EPIZYME INC | 50,000 | $436K | 0.1% | $8.72 | — | COM | 29428V104 |
| — | HARPOON THERAPEUTICS INC | 20,000 | $418K | 0.1% | $20.90 | — | COM | 41358P106 |
| — | ACHILLES THERAPEUTICS PLC | 25,000 | $414K | 0.1% | $16.56 | — | SPONSORED ADS | 00449L102 |
| CTMX | CYTOMX THERAPEUTICS INC | 50,000 | $387K | 0.1% | $7.92 | 0.0% | COM | 23284F105 |
| — | CEREVEL THERAPEUTICS HLDNG I | 72,466 | $312K | 0.1% | $5.64 | — | *W EXP 06/09/2020 | 15678U102 |
| — | WINDTREE THERAPEUTICS INC | 42,847 | $105K | 0.0% | $2.45 | — | COM | 97382D303 |
| — | VESPER HEALTHCARE ACQSTN COR | 45,000 | $94,000 | 0.0% | $2.50 | — | *W EXP 09/30/2027 | 92538T112 |
| — | ZYNERBA PHARMACEUTICALS INC | 13,285 | $62,000 | 0.0% | $3.31 | — | COM | 98986X109 |